Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

CoviCept Therapeutics
San Diego, CA

CoviCept Therapeutics, Inc. is a newly founded company based in San Diego, USA, focused on the development of a small molecule that inhibits the replication and spread of RNA viruses, including SARS-Cov-2. CoviCept is developing a small molecule that targets a host protein that is critical for RNA viral replication and that has shown efficacy in a preclinical model of SARS-CoV-2 infection, and in cell cultures infected with various RNA viruses including Zika and Dengue. The lead molecule has shown good tolerability, availability and biodistribution in humans.

Key Contact
Name
Sotirios Tsimikas
Title
Co-Founder
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
01/19/21 $2,300,000 Seed Forbion Capital Partners
undisclosed